DOACs on the rise: easier to use and less risky – DOQ
Editing 30 September 2024 The number of DOAC (direct acting oral anticoagulants) users has doubled in five years. At the same time, only a quarter of patients are still taking a vitamin K antagonist (VKA) as an oral anticoagulant. Martin Hemels, a cardiologist at Rijnstate in Arnhem and Radboud University Medical Center Nijmegen, finds that … Read more